Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials
ConclusionsIntravenous TNK-tPA 0.2 mg/kg administered within 3 hours of symptom onset seems to be well tolerated and effective option in patients with acute ischemic stroke.Trial RegistrationClinical Trials Registry —India,www.ctri.nic.in; unique identifiers: CTRI/2009/091/000251 and CTRI/2015/02/005556.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Activase | Brain | Cardiology | Cardiovascular | Disability | Heart | Hemorrhagic Stroke | History of Medicine | India Health | Ischemic Stroke | Neurology | Stroke | Study